Supplementary Table S9 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression

Supplementary Table S9 from SPOP Mutations Target STING1 Signaling in Prostate Cancer and Create Therapeutic Vulnerabilities to PARP Inhibitor–Induced Growth Suppression

<p>Supplementary Table S9. Quantification of each protein-specific band normalized to vinculin (Dox-inducible C4-2b–derived models, Fig. 4D, upper panel).</p>

Guardat en:
Dades bibliogràfiques
Autor principal: Chuandong Geng (17315310) (author)
Altres autors: Man-Chao Zhang (17315313) (author), Ganiraju C. Manyam (17315316) (author), Jody V. Vykoukal (17315319) (author), Johannes F. Fahrmann (15052230) (author), Shan Peng (17315322) (author), Cheng Wu (17315325) (author), Sanghee Park (17315328) (author), Shakuntala Kondraganti (17315331) (author), Daoqi Wang (17315334) (author), Brian D. Robinson (16755326) (author), Massimo Loda (14958363) (author), Christopher E. Barbieri (15012150) (author), Timothy A. Yap (15028749) (author), Paul G. Corn (17315337) (author), Samir Hanash (17314360) (author), Bradley M. Broom (15022580) (author), Patrick G. Pilié (15119957) (author), Timothy C. Thompson (17315340) (author)
Publicat: 2025
Matèries:
Cancer
Molecular and Cellular Biology
Therapeutic Research and Development
Cell Signaling
DNA Damage and Repair
Drug Mechanisms
Genitourinary Cancers
Prostate cancer
Small Molecule Agents
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars